Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD)

Respiratory Medicine

Volumn 107, Issue 5, 2013, Pages 724-731

  Izquierdo Alonso, José Luis ^a   Rodriguez Gonzálezmoro, Jose Miguel ^b   De Lucas Ramos, Pilar ^b   Unzueta, Irune ^c   Ribera, Xabier ^d   Antón, Esther ^e   Martín, Antonio ^c  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c PFIZER INC   (United States)

^d Medical Department   (Spain)

^e HOSPITAL DE MÓSTOLES   (Spain)

Author keywords

Clinical characteristics; COPD; Phenotype

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IPRATROPIUM BROMIDE; THEOPHYLLINE; TIOTROPIUM BROMIDE;

AGED; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; FEMALE; HOSPITAL ADMISSION; HUMAN; LUNG EMPHYSEMA; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTPATIENT CARE; OXYGEN THERAPY; PHENOTYPE; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SLEEP DISORDERED BREATHING; STRATIFICATION;

ACTIVITIES OF DAILY LIVING; AGED; ASTHMA; BRONCHITIS; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH SERVICES; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; QUALITY OF LIFE; SPAIN;

EID: 84876065048     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.01.001     Document Type: Article

References (38)

1. B. Burrows, C.M. Fletcher, B.E. Heard, N.L. Jones, and J.S. Wootliff The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago Lancet 1 1966 830 835
2. J.B. Snoeck-Stroband, T.S. Lapperre, M.M. Gosman, H.M. Boezen, W. Timens, N.H. ten Hacken Corticosteroids in Obstructive Lung Disease (GLUCOLD) Study Group Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies Eur Respir J 31 2008 70 77
3. D.F. Rogers The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options COPD 2 2005 341 353
4. M. Miravitlles Cough and sputum production as risk factors for poor outcomes in patients with COPD Respir Med 105 2011 1118 1128
5. V. Kim, M.K. Han, G.B. Vance, B.J. Make, J.D. Newell, and J.E. Hokanson The chronic bronchitic phenotype of COPD: an analysis of the COPDGene study Chest 140 2011 626 633
6. M. Hardin, E.K. Silverman, R.G. Barr, N.N. Hansel, J.D. Schroeder, B.J. Make COPDGene Investigators The clinical features of the overlap between COPD and asthma Respir Res 12 2011 127
7. M. Bafadhel, S. McKenna, S. Terry, V. Mistry, C. Reid, and P. Haldar Acute exacerbations of chronic obstructive pulmonary disease: identification of biological clusters and their biomarkers Am J Respir Crit Care Med 184 2011 662 671
8. J.R. Hurst Exacerbation phenotyping in chronic obstructive pulmonary disease Am J Respir Crit Care Med 184 2011 625 626
9. J.J. Soler-Cataluña, B. Cosío, and J.L. Izquierdo Consensus document on the overlap phenotype COPD-asthma in COPD Arch Bronconeumol 48 2012 331 337
10. M. Kraft Asthma and chronic obstructive pulmonary disease exhibit common origins in any country Am J Respir Crit Care Med 147 2006 238 240 [discussion 243-4]
11. A. Agusti, P.M. Calverley, B. Celli, H.O. Coxson, L.D. Edwards, D.A. Lomas Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators Characterisation of COPD heterogeneity in the ECLIPSE cohort Respir Res 10 11 2010 122
12. S.I. Rennard, and J. Vestbo The many "Small COPDs": COPD should Be an orphan disease Chest 134 2008 623 627
13. A. Punturieri, T.L. Croxton, G.G. Weinmann, and J.P. Kiley Chronic obstructive pulmonary disease: a view from the NHLBI Am J Respir Crit Care Med 178 2008 441 443
14. J.R. Hurst, J. Vestbo, A. Anzueto, N. Locantore, H. Müllerova, R. Tal-Singer Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators Susceptibility to exacerbation in chronic obstructive pulmonary disease N Engl J Med 363 2010 1128 1138
15. J. Vestbo, L.D. Edwards, P.D. Scanlon, J.C. Yates, A. Agusti, P. Bakke For the ECLIPSE Investigators Changes in forced expiratory volume in 1 second over time in COPD N Engl J Med 365 2011 1184 1192
16. J.B. Soriano, K.J. Davis, B. Coleman, G. Visick, D. Mannino, and N.B. Pride The proportional Venn diagram of obstructive lung disease Chest 124 2003 474 481
17. J. Garcia-Aymerich, F.P. Gómez, M. Benet, E. Farrero, X. Basagaña, à. Gayete PAC-COPD Study Group Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes Thorax 66 2011 430 437
18. S.E. Marsh, J. Travers, M. Weatherall, M.V. Williams, S. Aldington, and P.M. Shirtcliffe Proportional classifications of COPD phenotypes Thorax 63 2008 761 767
19. M. Pistolesi, G. Camiciottoli, M. Paoletti, C. Marmai, F. Lavorini, and E. Meoni Identification of a predominant COPD phenotype in clinical practice Respir Med 102 2008 367 376
20. M. Weatherall, J. Travers, P.M. Shirtcliffe, S.E. Marsh, M.V. Williams, and M.R. Nowitz Distinct clinical phenotypes of airways disease defined by cluster analysis Eur Respir J 34 2009 812 818
21. G.R. Washko Rate of decline in FEV1: is emphysema the culprit? Am J Respir Crit Care Med 185 2012 2 3
22. P.G. Gibson, and J.L. Simpson The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 64 2009 728 735
23. M. Saetta, W.D. Kim, J.L. Izquierdo, H. Ghezzo, and M.G. Cosio Extent of centrilobular and panacinar emphysema in smokers' lungs: pathological and mechanical implications Eur Respir J 7 1994 664 671
24. B. Burrows, J.W. Bloom, G.A. Traver, and M.G. Cline The course and prognosis of different forms of chronic airways obstruction in a sample from the general population N Engl J Med 317 1987 1309 1314
25. J.L. Izquierdo, and J. Aparicio Roflumilast for COPD Drugs Today 46 2010 823 831
26. R. Siva, R.H. Green, C.E. Brightling, M. Shelley, B. Hargadon, and S. McKenna Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial Eur Respir J 29 2007 906 913
27. A. Papi, M. Romagnoli, S. Baraldo, F. Braccioni, I. Guzzinati, and M. Saetta Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease Am J Respir Crit Care Med 162 2000 1773 1777
28. J.L. Izquierdo Alonso, I. Sánchez Hernández, J. Fernández Francés, J. Castelao Naval, F. Carrillo Arias, and J. Gallardo Carrasco Utility of transfer factor to detect different bronchodilator responses in patients with chronic obstructive pulmonary disease Respiration 65 1998 282 288
29. J.F. Dummer, M.J. Epton, J.O. Cowan, J.M. Cook, R. Condliffe, and E. Landhuis Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide Am J Respir Crit Care Med 180 2009 846 852
30. J.A. Wedzicha, and T.A. Seemungal COPD exacerbations: defining their cause and prevention Lancet 370 2007 786 796
31. L.M. Fabbri, B. Beghé, and A. Agusti Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines Thorax 66 2011 745 747
32. C.L. Chang, S.C. Robinson, G.D. Mills, G.D. Sullivan, N.C. Karalus, and J.D. McLachlan Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD Thorax 66 2011 764 768
33. A.D. Hoiseth, A. Neukamm, B.D. Karlsson, T. Omland, P.H. Brekke, and V. Soyseth Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease Thorax 66 2011 775 781
34. P.R. Burgel, P. Nesme-Meyer, P. Chanez, D. Caillaud, P. Carré, and T. Pérez Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects Chest 135 2009 975 982
35. M.K. Han, E.A. Kazerooni, D.A. Lynch, L.X. Liu, S. Murray, and J.L. Curtis Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes Radiology 261 2011 274 282
36. M. Miniati, S. Monti, J. Stolk, G. Mirarchi, F. Falaschi, and R. Rabinovich Value of chest radiography in phenotyping chronic obstructive pulmonary disease Eur Respir J 31 2008 509 515
37. M. Miniati, E. Filippi, F. Falaschi, L. Carrozzi, E. Milne, and H. Sostman Radiologic evaluation of emphysema in patients with chronic obstructive pulmonary disease. Chest radiography versus high resolution computed tomography Am J Respir Crit Care Med 151 1995 1359 1367
38. M. Nishimura, H. Makita, and K. Nagai Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease Am J Respir Crit Care Med 185 2012 44 52